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Introduction: Acne vulgaris is one of the most common skin disorders, which 
various factors are involved in its pathogenesis. Recent investigations on 
intracellular signaling pathway show that the over expression of mTORC1 complex 
(mammalian target of rapamycin), leads to increased sebum production and altered 
keratinization, therefore it has an important role in acne pathogenesis. Another 
studies also showed that the expression of mTORC1 is significantly increased in the 
skin cells of the patients, which confirm the linkage between acne pathogenesis and 
mTORC1 over expression. The aim of this study is to represent a way to confront 
the impaired endocrine signaling, in order to relieve the acne symptoms. 
 
 
Methods and Results: The linkage between acne pathogenesis and endocrine 
signaling pathway was demonstrated through the collected signaling data from 
popular scientific databases such as www.Kegg.Jp. Insulin resistance is one of the 
major factors that leads to mTORC1 over expression. Metformin, a biguaniide that 
increases the cell's sensitivity to insulin, is the drug of choice for this condition, as it 
is able to suppress mTORC1 over expression through AMPK (5' adenosine 
monophosphate-activated protein kinase) activation. So, applying a topical form of 
the drug on acne spots, may lead to relieve the symptoms. Topical semi solid 
formulation of metformin was prepared with the use of suitable thickening polymers 
and formulation was optimized through the point of viscosity and rheological 
behaviors of the aqueous gel, so the optimum ratio of the thickening polymers was 
determined. 
 
Conclusions: Signaling pathways show that acne pathogenesis is mediated through 
mTORC1 over activation, so we were aimed to design a formulation which is able to 
suppress this over expression in order to relieve acne symptoms. Metformin, 
formulated in a topical form, is the drug of choice, as it is a safe drug which can 
suppress the mTORC1 over expression through AMPK activation in the skin of acne 
patients. 
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